Abstract
Purpose of Review: There is evidence from epidemiologic studies that variability in cardiovascular risk factors influences risk of cardiovascular disease. We review new studies and novel findings in the relationship between visit-to-visit glycemic variability and blood pressure variability and risk of adverse outcomes. Recent Findings: Visit-to-visit glycemic variability is consistently linked to macrovascular disease. This relationship has been observed in both clinical trials and retrospective studies of electronic health records. Long-term blood pressure variability also predicts cardiovascular outcomes, and the association appears stronger in those with lower levels of systolic and diastolic function. Summary: As epidemiologic evidence increases in support of a role for metabolic risk factor variability in cardiovascular risk, there is a corresponding rise in interest in applying this information toward improving risk factor prediction and treatment. Future investigation of underlying mechanisms for these associations as well as implications for therapy is also warranted. The potential additive contribution of variability of multiple parameters also merits additional scrutiny. As our technology for capturing risk factor variability continues to improve, this will only enhance our understanding of its links with vascular disease and how to best utilize this information to reduce cardiovascular outcomes.
Original language | English (US) |
---|---|
Article number | 25 |
Journal | Current Cardiology Reports |
Volume | 23 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2021 |
Keywords
- Clinical trials
- Coronary hypoperfusion
- Macrovascular disease
- Mechanisms
- Risk factor variability
- Type 2 diabetes
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine